Fundamentals Overview
United Therapeutics Corporation is in the middle of its 52-week range with premium valuation, trending downward today.
Valuation premium
Intrinsic value (DCF)
+50.3% upside vs price
Profitability
Risk (Beta)
0.56 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +50.3% upside vs price · Analyst grade: A- · Sentiment improving (1 upgrade)
Pressures (Sell):
3M vs S&P 500: -13.2% · 3M vs Healthcare sector: -25.8%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Equal Weight: 7, Neutral: 2, Outperform: 6, Overweight: 4.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $774.60; current price is $515.50. That’s a +50.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 18.01 |
| DCF value (model) | $774.60 (50.3% upside) |
| PEG (TTM) | 3.25 |
| P/B (TTM) | 3.43 |
| P/S (TTM) | 6.94 |
| P/FCF (TTM) | 20.02 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 5.73 |
| Quick Ratio (TTM) | 5.41 |
| Cash Ratio (TTM) | 2.97 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 41.56% |
| Gross margin (TTM) | 86.14% |
| Operating margin (TTM) | 44.49% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for UTHR.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| JP Morgan | maintain | Overweight | Overweight | 2026-07-23 |
| B of A Securities | maintain | Neutral | Neutral | 2026-07-10 |
| RBC Capital | maintain | Outperform | Outperform | 2026-07-07 |
| RBC Capital | maintain | Outperform | Outperform | 2026-05-07 |
| Wells Fargo | upgrade | Equal Weight | Overweight | 2026-05-07 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-10 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-03-31 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-31 |
| B of A Securities | maintain | Neutral | Neutral | 2026-03-31 |
| TD Cowen | maintain | Buy | Buy | 2026-03-30 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-03-23 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-03-12 |
| UBS | maintain | Buy | Buy | 2026-03-05 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-02-26 |
| TD Cowen | maintain | Buy | Buy | 2026-02-26 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-26 |
| RBC Capital | maintain | Outperform | Outperform | 2026-02-26 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-02-26 |
| UBS | maintain | Buy | Buy | 2026-01-06 |
| UBS | maintain | Buy | Buy | 2025-11-06 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-10-30 |
| RBC Capital | maintain | Outperform | Outperform | 2025-10-30 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-10-30 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-10-10 |
| UBS | maintain | Buy | Buy | 2025-09-29 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-09-10 |
| Oppenheimer | maintain | Outperform | Outperform | 2025-09-05 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-09-05 |
| UBS | maintain | Buy | Buy | 2025-09-04 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-09-03 |